T. Shirotani

758 total citations
11 papers, 623 citations indexed

About

T. Shirotani is a scholar working on Molecular Biology, Surgery and Physiology. According to data from OpenAlex, T. Shirotani has authored 11 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Surgery and 3 papers in Physiology. Recurrent topics in T. Shirotani's work include Pancreatic function and diabetes (4 papers), Diabetes and associated disorders (3 papers) and Diabetes Treatment and Management (2 papers). T. Shirotani is often cited by papers focused on Pancreatic function and diabetes (4 papers), Diabetes and associated disorders (3 papers) and Diabetes Treatment and Management (2 papers). T. Shirotani collaborates with scholars based in Japan, United States and South Korea. T. Shirotani's co-authors include Eiichi Araki, Kunio Matsumoto, Junji Kawashima, Mihoshi Suefuji, Takeshi Nishikawa, Kenshi Ichinose, Michael Brownlee, Kazuhiko Nakamaru, Yoshiaki Hirashima and Fumihiko Kanai and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Biochemical and Biophysical Research Communications.

In The Last Decade

T. Shirotani

11 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Shirotani Japan 8 316 183 162 138 98 11 623
Taishan Zheng China 14 344 1.1× 214 1.2× 83 0.5× 207 1.5× 207 2.1× 32 662
P.J. Snodgrass United States 10 194 0.6× 130 0.7× 117 0.7× 85 0.6× 38 0.4× 17 561
H Mochizuki United States 7 305 1.0× 94 0.5× 90 0.6× 137 1.0× 38 0.4× 15 565
S Spagnuolo Italy 16 286 0.9× 131 0.7× 68 0.4× 194 1.4× 40 0.4× 49 612
Michel Kaufmann Switzerland 10 327 1.0× 154 0.8× 70 0.4× 191 1.4× 137 1.4× 11 745
Marisa Viñals Spain 10 332 1.1× 398 2.2× 161 1.0× 175 1.3× 48 0.5× 13 873
Eileen Sutherland United States 16 292 0.9× 256 1.4× 59 0.4× 119 0.9× 121 1.2× 20 1.0k
Shaonin Ji United States 12 294 0.9× 42 0.2× 122 0.8× 129 0.9× 58 0.6× 14 566
Z Rymaszewski United States 12 212 0.7× 126 0.7× 87 0.5× 173 1.3× 135 1.4× 28 642
Jacques Grober France 15 310 1.0× 430 2.3× 277 1.7× 67 0.5× 72 0.7× 19 889

Countries citing papers authored by T. Shirotani

Since Specialization
Citations

This map shows the geographic impact of T. Shirotani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Shirotani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Shirotani more than expected).

Fields of papers citing papers by T. Shirotani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Shirotani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Shirotani. The network helps show where T. Shirotani may publish in the future.

Co-authorship network of co-authors of T. Shirotani

This figure shows the co-authorship network connecting the top 25 collaborators of T. Shirotani. A scholar is included among the top collaborators of T. Shirotani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Shirotani. T. Shirotani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Park, Kyong Soo, Juliana C.N. Chan, Lee‐Ming Chuang, et al.. (2008). A mitochondrial DNA variant at position 16189 is associated with type 2 diabetes mellitus in Asians. Diabetologia. 51(4). 602–608. 85 indexed citations
2.
Matsumoto, Kunio, Takeshi Nishikawa, Mihoshi Suefuji, et al.. (2003). Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic β-cells. Biochemical and Biophysical Research Communications. 300(1). 216–222. 270 indexed citations
3.
Toyonaga, Tomomi, Tatsuya Kondo, Nobuhiro Miyamura, et al.. (2002). Sudden onset of diabetes with ketoacidosis in a patient treated with FK506/tacrolimus. Diabetes Research and Clinical Practice. 56(1). 13–18. 16 indexed citations
4.
Sakai, Masakazu, Takeshi Matsumura, Takeshi Biwa, et al.. (2000). Group-II phospholipase A2 enhances oxidized low density lipoprotein-induced macrophage growth through enhancement of GM-CSF release. Atherosclerosis. 153(1). 37–46. 6 indexed citations
7.
Ura, Seiji, Eiichi Araki, Hiroki Kishikawa, et al.. (1996). Molecular scanning of the insulin receptor substrate-1 (IRS-1) gene in Japanese patients with NIDDM: identification of five novel polymorphisms. Diabetologia. 39(5). 600–608. 9 indexed citations
8.
Kisanuki, Koichi, Hiroki Kishikawa, Eiichi Araki, et al.. (1995). Expression of insulin receptor on clonal pancreatic alpha cells and its possible role for insulin-stimulated negative regulation of glucagon secretion. Diabetologia. 38(4). 422–429. 5 indexed citations
9.
Murakami, T., Takeshi Nishiyama, T. Shirotani, et al.. (1992). Identification of two enhancer elements in the gene encoding the type 1 glucose transporter from the mouse which are responsive to serum, growth factor, and oncogenes.. Journal of Biological Chemistry. 267(13). 9300–9306. 109 indexed citations
10.
Araki, Eiichi, T. Shirotani, Fumihiko Kanai, et al.. (1991). A cluster of four Sp1 binding sites required for efficient expression of the human insulin receptor gene. Journal of Biological Chemistry. 266(6). 3944–3948. 80 indexed citations
11.
Minaguchi, Kiyoshi, T. Shirotani, & Kazuo Suzuki. (1988). New variants of Ps salivary polymorphic proteins. Annals of Human Genetics. 52(1). 11–16. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026